March 2026 - Page 23 of 27

FridayMar 06, 2026 9:00 am

QualityStocksNewsBreaks – VolitionRx Limited (NYSE American: VNRX) Completes Automation Validation for Nu.Q Vet Cancer Test in Japan

VolitionRx (NYSE American: VNRX) announced the successful validation and verification of the chemiluminescent immunoassay version of its Nu.Q Vet Cancer Test with Fujifilm Vet Systems Co. Ltd in Japan, enabling full automation in central laboratories through the IDS i10 automated analyzer platform. The company said the transition from manual plates to automated processing is expected to support faster turnaround and higher throughput as demand grows, with more than 1,700 veterinary hospitals in Japan already registered to use the test. Volition highlighted Japan’s approximately seven million pet dogs and noted the automated platform aligns with the same system used for its…

ThursdayMar 05, 2026 11:15 am

MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF) Begins Strategic Drilling at Bracken to Expand Basin-Scale Natural Hydrogen Potential

Disseminated on behalf of MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF) and may include paid advertising. “We’re excited about the potential of this second play concept to deliver meaningful results and demonstrate basin-scale continuity for natural hydrogen in Saskatchewan,” said CEO. The Bracken well will test what MAX Power describes as a “stratigraphic play concept.” The strategic importance of the Bracken drilling program goes beyond geological exploration. MAX Power Mining (CSE: MAXX) (OTC: MAXXF) has launched an exciting new phase in its natural hydrogen exploration campaign with the commencement of drilling at its Bracken target. This significant milestone could…

ThursdayMar 05, 2026 11:07 am

QualityStocksNewsBreaks – Frontieras North America Appoints Nora Shepard as Vice President of Communications

Frontieras North America, an energy and environmental technology company commercializing its patented FASForm(TM) Solid Carbon Fractionation process, today announced the appointment of Nora Shepard as vice president of communications as the company advances commercialization of its first FASForm(TM) facility in Mason County, West Virginia and expands engagement with institutional investors, strategic partners and policymakers. In her new role, Shepard will oversee corporate communications, investor messaging, brand strategy and executive positioning, supporting Frontieras’ efforts to align operational execution with capital markets strategy as it progresses toward deployment of its flagship facility designed to process 7,500 tons of coal per day. To view the full press release, visit https://ibn.fm/OrFQa About Frontieras North…

ThursdayMar 05, 2026 10:53 am

QualityStocksNewsBreaks – MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Named Finalist for Three Awards at 2026 Canadian Hydrogen Convention

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) announced that the company and CEO Ran Narayanasamy have been selected as finalists for three awards to be presented at the 2026 Canadian Hydrogen Convention in Edmonton, scheduled for April 21-23. MAX Power is a finalist for both the Hydrogen Project Award and the Digital Innovation Award, while Narayanasamy has been nominated for the Emerging Hydrogen Leader Award. Narayanasamy will also moderate the convention’s first panel discussion on natural hydrogen exploration in Canada on April 22, highlighting the company’s leadership…

ThursdayMar 05, 2026 10:30 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Advances Processing Strategy amid Rising Rare Earth Prices

Disseminated on behalf of Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) and may include paid advertising. The prices for the rare earths most critical to automotive and high-tech manufacturing have climbed 37 to 105% since the start of the year. “These price differentials . . . underscore the importance of the developing North American supply chain,” said Ucore CEO. Demonstration data supports deployment at Ucore’s planned Strategic Metals Complex, where the first commercial RapidSX unit is targeted for commissioning in 2026. Rare earth element prices have moved sharply higher in recent months, reflecting tightening global supply and sustained demand from…

ThursdayMar 05, 2026 9:55 am

QualityStocksNewsBreaks – Massimo Group (NASDAQ: MAMO) Secures Authorization for Core Product Placement Across 1,000 U.S. Retail Locations

Massimo Group (NASDAQ: MAMO) a manufacturer and distributor of powersports vehicles, utility vehicles and related equipment, announced that a long-standing national rural lifestyle retail partner has authorized one of the company’s core products for placement across 1,000 U.S. retail locations. The initial rollout will include approximately 2,400 units supported through both physical retail stores and the retailer’s online platform, establishing an integrated omnichannel sales approach and creating a scalable pathway for potential expansion across the retailer’s roughly 2,200 U.S. locations, subject to performance and ongoing evaluation. To view the full press release, visit https://ibn.fm/9qYsY About Massimo Group (NASDAQ: MAMO) Massimo Group…

ThursdayMar 05, 2026 9:45 am

Soligenix Inc. (NASDAQ: SNGX) Leverages Platform Science for Broader Therapeutic Reach

Platform-based drug development has gained traction across the biotechnology industry because of its efficiency and risk management advantages. Soligenix’s development of synthetic hypericin illustrates this “one drug, multiple diseases” model in action. HyBryte is being developed to treat both cutaneous T-cell lymphoma (“CTCL”), a rare form of non-Hodgkin lymphoma that primarily affects the skin, and psoriasis. Modern biopharmaceutical innovation often revolves around a powerful idea: One scientific mechanism can unlock treatments for multiple diseases. Rather than building entirely new molecules for every indication, companies are developing platform technologies that allow a single therapeutic approach to be adapted across conditions. Soligenix…

ThursdayMar 05, 2026 9:00 am

Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) Secures $807,000 from Warrant Exercises to Advance Murdock Mountain Project

Disseminated on behalf of Nevada Organic Phosphate Inc. (CSE: NOP) (OTCQB: NOPFF) and may include paid advertising. Nevada Organic Phosphate, targeting the growing need for phosphate fertilizer for the expanding organic foods market, has received proceeds from the exercise of 14.6 million warrants. The company’s cash on hand now totals approximately $1.25 million, and the capital will help support Phase II drilling at the Murdock Mountain Project in Nevada. The Murdock Mountain deposit may represent one of the only large-scale organic sedimentary phosphate resources in North America. Remaining warrants could generate roughly $2.46 million if exercised. Nevada Organic Phosphate (CSE:…

ThursdayMar 05, 2026 8:52 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Enrolls First Patients in ALIGN-ACS Pilot Study for Heart Attack Detection

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced the enrollment of the first patients in its ALIGN-ACS pilot study evaluating the HeartBeam System for heart attack detection. The first patients were enrolled by Prof. Dr. Vladan Vukcevic at the University Clinical Center of Serbia in Belgrade, marking a key step toward generating the clinical data needed to expand the HeartBeam System’s indication beyond arrhythmia assessment to include heart attack detection. To view the full press release, visit https://ibn.fm/afbcv About HeartBeam, Inc. HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming the detection and monitoring of critical cardiac conditions. The Company…

ThursdayMar 05, 2026 8:52 am

QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Schedules March 12 Conference Call to Review Q4 and Full-Year 2025 Results

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through advanced cardiac insights, will host a conference call at 4:30 p.m. Eastern time on March 12, 2026, to discuss its financial results for the fourth quarter and full year ended Dec. 31, 2025, and provide updates on key strategic growth initiatives, including the limited commercial launch and progress on its 12-lead ECG extended wear patch. A press release detailing the results will be issued prior to the call. To view the full press release, visit https://ibn.fm/x2atK About HeartBeam, Inc. HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming…

Site Search

Company Search

Month: March 2026